Back to the records

Study

Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure.

Barbara Olasov Rothbaum, Megan C Kearns, Matthew Price, Emily Malcoun, Michael Davis, Kerry J Ressler, Delia Lang, Debra Houry · Biological psychiatry · 2012

Read the original paper ↗

The short version

This randomized pilot study with 137 civilian trauma patients explored whether starting psychotherapy within hours of a traumatic event, before the memory of the event fully consolidates (the process by which an experience becomes a stable, long-term memory), could prevent posttraumatic stress disorder (PTSD) from developing. The intervention was a modified version of prolonged exposure (PE), a therapy that reduces conditioned fear responses by having a person repeatedly revisit a feared memory in a safe setting until the fear response diminishes, a process known as fear extinction. Because most PTSD treatments begin only after symptoms are already established, this trial tested the therapy as prevention rather than as treatment of chronic illness. Participants were adults aged 18 to 65 who arrived at a Level One trauma center emergency department within 72 hours of a qualifying trauma; 137 were randomly assigned to three one-hour sessions of modified PE, delivered one week apart and beginning in the emergency department, or to assessment only. The modified PE sessions involved guided recounting of the trauma memory, discussion of the traumatic experience, and take-home exposure exercises. Blinded evaluators measured posttraumatic stress severity with a structured clinical interview (the PSS-I) and depression with a standard self-report questionnaire (the BDI-II) at 4 and 12 weeks after enrollment. Participants who received the intervention reported significantly lower posttraumatic stress severity than the assessment-only group at 4 weeks (19.09 vs. 24.54 points, p = 0.02 for the overall treatment effect) and 12 weeks (15.47 vs. 20.33 points), representing a medium-sized benefit (Cohen's d of 0.34 to 0.38, a standard measure of effect strength where 0.2 is considered small and 0.8 is considered large). By 12 weeks, significantly more intervention participants no longer met PTSD criteria than controls (74% vs. 53%, p = 0.04). Depression scores at 4 weeks were also significantly lower in the intervention group (p < 0.01, d = 0.35). The benefit was largest among rape victims, who showed a large effect (d = 0.70) at 4 weeks, notable because sexual assault carries among the highest known risk of developing PTSD. The intervention did not significantly reduce symptoms tied to participants' earlier, unrelated traumas, suggesting its effect was specific to the event that brought them to the emergency department. The findings suggest that exposure-based psychotherapy can be safely delivered within hours of trauma, in an emergency department, before a traumatic memory becomes consolidated. The authors note important limitations: no baseline PTSD measure was collected, since assessing symptoms so soon after trauma was judged invalid, so only between-group comparisons were possible; the sample was pilot-sized and not powered for smaller effects; and roughly a quarter to a third of participants did not complete follow-up assessments. The authors describe the results as establishing feasibility and call for larger replication trials.

Key findings

  • In a pilot randomized controlled trial of 137 civilian trauma patients, three sessions of a modified prolonged exposure (PE) intervention -- a psychotherapy that uses repeated, guided recounting of the trauma memory (imaginal exposure) alongside real-world exposure homework -- begun in the emergency department reduced posttraumatic stress symptom severity compared with an assessment-only control group at both 4 weeks (p < .01) and 12 weeks (p < .05).
  • Participants who received the intervention also reported significantly lower depression scores on the Beck Depression Inventory-II at 4 weeks than the assessment-only group (p < .05).
  • The benefit was largest among rape victims, a subgroup at especially high risk for developing PTSD, who showed a large effect size (Cohen's d = 0.70) at 4 weeks.
  • The intervention's effects did not extend to posttraumatic stress symptoms tied to participants' prior traumatic experiences, only to the trauma that brought them to the emergency department.
  • The study reported no intervention-related adverse events, but its pilot design, lack of a pre-treatment PTSD baseline, and dropout of roughly a quarter to a third of participants by follow-up limit how strongly the findings can be generalized.

Common questions

What healing modality was studied?

Modified Prolonged Exposure, an exposure-based psychotherapy technique within Mind-Body Medicine, delivered as a brief early intervention beginning in a hospital emergency department.

What condition was addressed?

Posttraumatic stress disorder (PTSD) symptoms following acute civilian trauma, with depressive symptoms also measured as a secondary outcome.

What were the main findings?

In this 137-participant randomized pilot trial, participants receiving three sessions of modified prolonged exposure reported significantly lower PTSD symptom severity than an assessment-only group at 4 weeks (p < 0.01) and 12 weeks (p < 0.05), and significantly lower depression at 4 weeks (p < 0.05); effects were strongest among rape victims (p = 0.004 at 4 weeks).

How strong is the evidence?

Moderate: a single randomized pilot controlled trial with blinded assessors and multiple imputation for missing data, but limited by the lack of a baseline PTSD measure, a pilot-scale sample, and substantial follow-up dropout.

What are the clinical implications?

The findings indicate that a brief exposure-based intervention initiated within hours of trauma, before memory consolidation, may be safe, feasible, and effective at reducing early psychological sequelae of trauma, particularly for sexual assault survivors. The authors state further research is needed on dosing, timing, and dissemination before broader implementation.

This summary and its findings were generated by AI from the published paper and may contain imperfections. It describes a study and is not medical advice — talk to a qualified clinician about your own health (terms). The original study is always the source of truth — read it above.